Advertisement
Screener

PURE Bioscience, Inc. (PURE) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

1.8 / 5 stars · 28/78 Roast Me

PURE Bioscience, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

PURE Bioscience, Inc. (PURE) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.12% for the 9-month period ending 2026-04-30, per its 10-Q filed 2026-06-15.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-06-15

  • PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2025-10-31 was 4.12%, a 6.74% increase year-over-year.
  • PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2025-04-30 was 4.47%.
  • PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2024-10-31 was 3.86%, a 7.66% decline year-over-year.
  • PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2023-10-31 was 4.18%, a 4.50% increase year-over-year.
  • PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2025 was 4.10%, a 1.91% decline from fiscal 2024.
  • PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2024 was 4.18%, a 4.50% increase from fiscal 2023.
  • PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 4.00%, a 241.88% increase from fiscal 2022.
  • PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2022 was 1.17%, a 27.17% increase from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 0 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 1 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month as first filed
2026-04-304.12%
10-Q · filed 2026-06-15
2026-01-314.12%
10-Q · filed 2026-03-17
2025-10-314.12%
10-Q · filed 2025-12-15
2025-07-314.10%
10-K · filed 2025-10-29
2025-04-304.47%
10-Q · filed 2025-06-16
4.17%
10-Q · filed 2026-06-15
2025-01-313.86%
10-Q · filed 2026-03-17
2024-10-313.86%
10-Q · filed 2025-12-15
2024-07-314.18%
10-K · filed 2025-10-29
2024-04-304.18%
10-Q · filed 2025-06-16
2024-01-314.18%
10-Q · filed 2025-03-17
2023-10-314.18%
10-Q · filed 2024-12-16
2023-07-314.00%
10-K · filed 2024-10-29
2023-04-304.00%
10-Q · filed 2024-06-14
2023-01-314.00%
10-Q · filed 2024-03-18
2022-10-314.00%
10-Q · filed 2023-12-14
2022-07-311.17%
10-K · filed 2023-10-30
2022-04-301.17%
10-Q · filed 2023-06-14
2022-01-311.36%
10-Q · filed 2022-03-15
1.17%
10-Q · filed 2023-03-17
2021-10-310.84%
10-Q · filed 2022-12-14
2021-07-310.92%
10-K · filed 2022-10-28
2021-04-300.18%
10-Q · filed 2022-06-14
2021-01-310.18%
10-Q · filed 2022-03-15
0.18%
10-Q · filed 2022-03-15
2020-10-310.00%
10-Q · filed 2020-12-15
2020-07-310.89%
10-K · filed 2021-10-28
2020-04-300.00%
10-Q · filed 2020-06-11
1.46%
10-Q · filed 2021-06-15
2020-01-311.46%
10-Q · filed 2021-03-15
1.43%
10-Q · filed 2021-03-15
2019-10-311.52%
10-Q · filed 2020-12-15
2019-07-312.63%
10-K · filed 2020-10-08
2019-04-302.55%
10-Q · filed 2020-06-11
2.63%
10-Q · filed 2020-06-11
2019-01-310.00%
10-Q · filed 2020-03-12
2.80%
10-Q · filed 2020-03-12
2018-10-312.80%
10-Q · filed 2019-12-13
2018-07-312.32%
10-K · filed 2019-10-30
2018-04-302.34%
10-Q · filed 2019-06-13
2.26%
10-Q · filed 2019-06-13
2018-01-312.03%
10-Q · filed 2019-03-06
1.91%
10-Q · filed 2019-03-06
2017-10-311.80%
10-Q · filed 2018-12-13
2017-07-311.70%
10-K · filed 2018-10-25
2017-04-301.51%
10-Q · filed 2018-06-13
1.48%
10-Q · filed 2018-06-13
2017-01-310.00%
10-Q · filed 2018-03-14
0.93%
10-Q · filed 2018-03-14
2016-10-310.93%
10-Q · filed 2017-12-14
2016-07-310.83%
10-K · filed 2017-10-26
2016-04-300.67%
10-Q · filed 2017-06-08
0.70%
10-Q · filed 2017-06-08
2016-01-310.92%
10-Q · filed 2017-03-02
0.92%
10-Q · filed 2017-03-02
2014-07-310.45%
10-K · filed 2015-10-28
2014-04-300.79%
10-Q · filed 2015-06-11
2013-07-3185.00%
10-K · filed 2014-10-28
0.85%
10-K · filed 2013-10-24
2013-04-300.85%
10-Q · filed 2013-06-14
2013-04-240.43%
10-Q · filed 2013-06-14
2013-04-170.44%
10-Q · filed 2013-06-14
2013-01-310.84%
10-Q · filed 2013-02-25
2012-07-310.75%
10-K · filed 2013-10-24
2012-06-290.24%
10-K · filed 2013-10-24
2012-04-301.17%
10-Q · filed 2013-06-14
2012-01-311.16%
10-Q · filed 2013-02-25